These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3219749)

  • 1. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers.
    Torre D; Sampietro C; Quadrelli C; Bianchi W; Maggiolo F
    Chemioterapia; 1988 Dec; 7(6):382-6. PubMed ID: 3219749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
    Washington C; Hou SY; Hughes NC; Campanella C; Berner B
    J Clin Pharmacol; 2007 Oct; 47(10):1320-6. PubMed ID: 17724088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of activated charcoal on the bioavailability of piroxicam in man.
    Laufen H; Leitold M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
    Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chloroquine on the bioavailability of ciprofloxacin in humans.
    Ilo CE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo JC; Agbasi PU; Orisakwe OE
    Am J Ther; 2006; 13(5):432-5. PubMed ID: 16988539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of superactivated charcoal administered to healthy volunteers.
    Sato RL; Wong JJ; Sumida SM; Yamamoto LG
    Hawaii Med J; 2002 Nov; 61(11):251-3. PubMed ID: 12516788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of orally administered activated charcoal on vancomycin clearance.
    Davis RL; Roon RA; Koup JR; Smith AL
    Antimicrob Agents Chemother; 1987 May; 31(5):720-2. PubMed ID: 3606073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characteristics of drugs and response to repeat-dose activated charcoal.
    Campbell JW; Chyka PA
    Am J Emerg Med; 1992 May; 10(3):208-10. PubMed ID: 1586429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of two brands of ciprofloxacin.
    Seth SD; Beotra A; Seth S
    J Assoc Physicians India; 1995 May; 43(5):327-30. PubMed ID: 9081961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability of two brands of ciprofloxacin: an Indian study.
    Suthakaran C; Rajaram S; Adithan C
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):66-8. PubMed ID: 1551749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of the body clearance of phenobarbital by oral activated charcoal.
    Berg MJ; Berlinger WG; Goldberg MJ; Spector R; Johnson GF
    N Engl J Med; 1982 Sep; 307(11):642-4. PubMed ID: 7050705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal.
    Boldy DA; Vale JA; Prescott LF
    Q J Med; 1986 Nov; 61(235):997-1002. PubMed ID: 3659250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chloroquine on the urinary excretion of ciprofloxacin.
    Ilo CE; Ezejiofor NA; Agbakoba N; Brown SA; Maduagwuna CA; Agbasi PU; Orisakwe OE
    Am J Ther; 2008; 15(5):419-22. PubMed ID: 18806516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of flecainide resorption by activated charcoal].
    Nitsch J; Köhler U; Lüderitz B
    Z Kardiol; 1987 May; 76(5):289-91. PubMed ID: 3113085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of ofloxacin and ciprofloxacin.
    Wolfson JS; Hooper DC
    Am J Med; 1989 Dec; 87(6C):31S-36S. PubMed ID: 2690617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.